Top Markets
#1 Palladium Network Palladium Network +27.91%
#2 Siren Siren +24.70%
#3 Ankr Network Ankr Network +21.97%
#4 Status Status +12.88%
#5 Pons Pons +12.30%
#6 BankrCoin BankrCoin +10.19%
#7 Wiki Cat Wiki Cat +8.00%
#8 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.23%
#9 WAX WAX +7.10%
#10 would would +6.89%
Coin of the day
Palladium Network Palladium Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
Rang in Aktien #18094
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Aktienkurs
$10.22
Zuletzt synchronisiert: 2026-07-31
Marktkapitalisierung
$212.97M
Veränderung (1 Tag)
4.58%
Veränderung (1 Jahr)
78.08%
Land
CA
Handel Satellos Bioscience Inc. (MSCL)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Satellos Bioscience Inc. (MSCL)
Dividendenrendite (TTM) von Satellos Bioscience Inc. (Aktienkürzel: MSCL) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Satellos Bioscience Inc. (MSCL) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.48%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH